MOG Antibody Status Is Associated With Distinct Clinical Profiles and Treatment Responses in Chronic Relapsing Inflammatory Optic Neuropathy.

Graure M, Nierobisch N, De Vere-Tyndall A, Pakeerathan T, Ayzenberg I, Gernert JA, Havla J, Ringelstein M, Aktas O, Tkachenko D, et al.

Neurol Neuroimmunol Neuroinflamm. 2026 Nov; 13(6):e200668. PMID: 42912877. Abstract